OTHER DISEASE STATES
There are multiple diseases that the Nasus drug delivery platform can address. They have large and expensive health and quality of life impacts.
- Migraine - 38 million patients in the US 1,2
- Alzheimer's Disease - 5 million patients in the US 3,4
- Vaccines - Flu vaccine saves 3 million lives a year worldwide 5
- There are several promising COVID vaccines that could be delivered intranasally 6,7,8
If you have other areas of interest or want to find out how to partner with Nasus Medical, please be in touch.
References:
1. Burch R, Rizzoli P, Loder E. The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies. Headache: The Journal of Head and Face Pain. 2018;58:496-505.
2. Grandview Research Report 2018 - Migraine.
3. Matthews KA, et al. Racial and ethnic estimates of Alzheimer’s disease and related dementias in the United States (2015-2060) in adults aged ≥65 years. Alzheimer’s & Dementia. 2019;15:17-24.
4. 2016 BCC Market Report: Alzheimer's Disease Therapuetics and Diagnostics. UfukEzer, ISBN: 1-62296-266-4.
5. 2018 BCC Market Report: Influenza Market, Melissa Elder, PHM049E.
6. https://www.ucsf.edu/news/2020/08/418241/aeronabs-promise-powerful-inhalable-protection-against-covid-19
7. https://medicine.wustl.edu/news/nasal-vaccine-against-covid-19-prevents-infection-in-mice/
8. https://altimmune.com/about-us/
